[Expression and Prognostic Value of MiR-155 in Patients with Chronic Lymphocytic Leukemia].

Wang, Fei; Xu, Wei; Gu, Wei-Ying; Li, Jian-Yong

Wang, Fei; Xu, Wei; Gu, Wei-Ying; Li, Jian-Yong.

Afiliação

Wang F; Department of Hematology, The Third Affiliated Hospital of Soochow University (The First People's Hospital of Changzhou), Changzhou 213003, Jiangsu Province, China.
Xu W; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial people Hospital), Nanjing 210029, Jiangsu Province, China.
Gu WY; Department of Hematology, The Third Affiliated Hospital of Soochow University (The First People's Hospital of Changzhou), Changzhou 213003, Jiangsu Province, China.
Li JY; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial people Hospital), Nanjing 210029, Jiangsu Province, China,E-mail: lijianyonglm@126.com.

Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 28(1): 34-39, 2020 Feb.

Article em Zh | MEDLINE | ID: mdl-32027250

Assuntos

Leucemia Linfocítica Crônica de Células B; MicroRNAs/genética; Humanos; Região Variável de Imunoglobulina; Hibridização in Situ Fluorescente; Leucemia Linfocítica Crônica de Células B/genética; Mutação; Prognóstico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / MicroRNAs Tipo de estudo: Prognostic_studies Limite: Humans Idioma: Zh Revista: Zhongguo Shi Yan Xue Ye Xue Za Zhi Assunto da revista: HEMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google